RedHill Biopharma’s Opaganib Demonstrates Complete Inhibition of SARS-CoV-2 September 8, 2020 GlobeNewswire Source: Medical Share on Facebook Share Share on TwitterTweet Share on Google Plus Share Share on Pinterest Share Share on LinkedIn Share Share on Digg Share